[{"address1": "1560 Trapelo Road", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "781 786 8230", "fax": "781 786 8866", "website": "https://www.dyne-tx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 240, "companyOfficers": [{"maxAge": 1, "name": "Mr. John G. Cox M.B.A.", "age": 61, "title": "CEO, President & Director", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 1028185, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Oxana  Beskrovnaya Ph.D.", "age": 63, "title": "Chief Innovation Officer", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 719521, "exercisedValue": 2172731, "unexercisedValue": 3736735}, {"maxAge": 1, "name": "Ms. Johanna  Friedl-Naderer", "age": 56, "title": "Chief Commercial Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 748769, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Douglas  Kerr M.B.A., M.D., Ph.D.", "age": 57, "title": "Chief Medical Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 745640, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Axel  Wiest", "title": "Senior VP and Head of Portfolio Strategy & Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Rajesh  Manchanda Ph.D.", "age": 58, "title": "Chief Technical Officer", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James P. Bilotta M.B.A.", "title": "Chief Digital & Information Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ranjan  Batra Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel  Wilson", "age": 52, "title": "Senior VP & Head of Legal", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lucia  Celona", "age": 58, "title": "Chief Human Resource Officer", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 8, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1764547200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 20.35, "open": 20.25, "dayLow": 19.68, "dayHigh": 20.3, "regularMarketPreviousClose": 20.35, "regularMarketOpen": 20.25, "regularMarketDayLow": 19.68, "regularMarketDayHigh": 20.3, "payoutRatio": 0.0, "beta": 1.303, "forwardPE": -6.0444837, "volume": 936540, "regularMarketVolume": 936540, "averageVolume": 2941458, "averageVolume10days": 2531010, "averageDailyVolume10Day": 2531010, "bid": 13.83, "ask": 23.95, "bidSize": 2, "askSize": 1, "marketCap": 3299631104, "fiftyTwoWeekLow": 6.36, "fiftyTwoWeekHigh": 26.22, "allTimeHigh": 47.45, "allTimeLow": 4.3, "fiftyDayAverage": 19.9221, "twoHundredDayAverage": 13.563825, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2190785792, "profitMargins": 0.0, "floatShares": 134205217, "sharesOutstanding": 164652236, "sharesShort": 14949400, "sharesShortPriorMonth": 17111938, "sharesShortPreviousMonthDate": 1763078400, "dateShortInterest": 1765756800, "sharesPercentSharesOut": 0.0908, "heldPercentInsiders": 0.0043599997, "heldPercentInstitutions": 0.98474, "shortRatio": 4.3, "shortPercentOfFloat": 0.0998, "impliedSharesOutstanding": 164652236, "bookValue": 4.851, "priceToBook": 4.1311073, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -423800992, "trailingEps": -3.62, "forwardEps": -3.31542, "enterpriseToEbitda": -4.899, "52WeekChange": -0.13953489, "SandP52WeekChange": 0.17354333, "quoteType": "EQUITY", "currentPrice": 20.04, "targetHighPrice": 60.0, "targetLowPrice": 17.0, "targetMeanPrice": 38.875, "targetMedianPrice": 39.5, "recommendationMean": 1.4375, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 16, "totalCash": 791886976, "totalCashPerShare": 5.544, "ebitda": -447184992, "totalDebt": 120466000, "quickRatio": 13.231, "currentRatio": 13.472, "debtToEquity": 17.414, "returnOnAssets": -0.34320998, "returnOnEquity": -0.60659003, "freeCashflow": -242117632, "operatingCashflow": -375710016, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "DYN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Dyne Therapeutics, Inc.", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1766783404, "regularMarketTime": 1766782801, "exchange": "NMS", "messageBoardId": "finmb_608699906", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1600349400000, "earningsTimestamp": 1762376400, "earningsTimestampStart": 1762376400, "earningsTimestampEnd": 1762376400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -3.62, "epsForward": -3.31542, "epsCurrentYear": -3.55085, "priceEpsCurrentYear": -5.6437197, "fiftyDayAverageChange": 0.11790085, "fiftyDayAverageChangePercent": 0.0059180935, "twoHundredDayAverageChange": 6.4761763, "twoHundredDayAverageChangePercent": 0.47745946, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-09-17", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "longName": "Dyne Therapeutics, Inc.", "postMarketChangePercent": 0.0, "postMarketPrice": 20.04, "postMarketChange": 0.0, "regularMarketChange": -0.309999, "regularMarketDayRange": "19.68 - 20.3", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2941458, "fiftyTwoWeekLowChange": 13.68, "fiftyTwoWeekLowChangePercent": 2.1509435, "fiftyTwoWeekRange": "6.36 - 26.22", "fiftyTwoWeekHighChange": -6.1799984, "fiftyTwoWeekHighChangePercent": -0.23569788, "fiftyTwoWeekChangePercent": -13.953489, "regularMarketChangePercent": -1.52334, "regularMarketPrice": 20.04, "displayName": "Dyne Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-12-27"}]